Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Seeking the right prescription in fight against antibiotic resistance

Research

As World Antibiotic Awareness Week aims to highlight the growing issue of antibiotic resistance, researchers at the University of Oxford have received funding to look at ways to improve the prescribing of antibiotics.

Image courtesy of Shutterstock

This is part of a larger investment of over £15.8 million into research to tackle into drug resistant infections, by the National Institute for Health Research (NIHR), the research arm of the NHS.

Sixteen studies have been funded as part of a call for more research into drug resistant infections, also known as antimicrobial resistance (AMR). Drug resistant infections present a major threat to the future of healthcare and by 2050 could result in 10 million avoidable deaths every year, from antibiotic resistant infections such as MRSA, sepsis and multi-drug-resistant mycobacterium tuberculosis.

Read more

Similar stories

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Three ways virtual reality could transform mental health treatment

General Research

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.